MedTrace Logo

Concepts for Analgosedation During Placement of Regional Anaesthesia Before Operations.

NCT04026074 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2019-10-21

No results posted yet for this study

Summary

Aim of the study is to specify the best analgosedation technique during placement of regional anaesthesia from the patients' view.

In this double blind randomized trial the investigators will be testing the application of drugs administered intravenously (fentanyl-bolus, remifentanil-infusion, clonidine-bolus) or transcutaneously (EMLA salve) or placebo (NaCl 0,9% i.v. and skin protection salve).

Conditions

  • Knee Arthropathy
  • Hip Arthritis
  • Fractures, Closed

Interventions

DRUG

Fentanyl

Weight adapted drug application

DRUG

Remifentanil

Weight adapted drug application

DRUG

Clonidine

Weight adapted drug application

DRUG

EMLA Cream

Salve application on the body part where the regional anaesthesia will be administered

DRUG

Placebo iv

i.v. administration of 0,9% NaCl

DRUG

Placebo salve

Skin protection salve (placebo salve) application on the body part where the regional anaesthesia will be administered

Sponsors & Collaborators

  • Medical University of Graz

    lead OTHER

Principal Investigators

  • Gregor A Schittek, MD · Medical University of Graz

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-26
Primary Completion
2019-10-16
Completion
2019-10-18

Countries

  • Austria

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04026074 on ClinicalTrials.gov